Clinical Trial Update: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial is evaluating tamibarotene for HTLV-1-associated myelopathy (HAM/TSP). The current status and results have not been disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1-associated Myelopathy

Drugs mentioned

• Tamibarotene (tamibarotene)

Snippet

Sponsor: St. Marianna University School of Medicine | Conditions: HTLV-I-Associated Myelopathy | Phase 2, Phase 3 | Status: UNKNOWN